Macular scan OCT could be used for glaucoma

Article

Macular scan OCT could be used for the diagnosis and management of glaucoma.

Macular scan OCT could be used for the diagnosis and management of glaucoma.

Dr Whitney Boling and her team, Department of Ophthalmology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, Indiana, studied the OCT macula scans and automated visual field (VF) defects of 127 eyes of 127 glaucoma patients.

The superior inner and outer sectors and the inferior inner and outer sectors were recorded by macular scan OCT. Superior outer, superior inner, inferior inner, and inferior outer rows were used to determine VFs. OCT macular scan sectors and VF rows were compared using the Spearman correlation.

There were statistically significant structural relationships between all macular parameters and the related VF defects. The highest correlations were between the inferior outer macular thickness and the superior outer VF region, the inferior inner macular and the superior inner VF region, the superior inner macula and the inferior inner VF region, and the superior outer macular and the inferior outer VF region.

Macular scan OCT should be considered as a tool for the diagnosis and management of glaucoma, due to the predictable and significant structural relationship between macular thickness and VF defects.

To read the abstract please visit the Journal of Glaucoma.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.